Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
11/08/2007 | WO2007126117A1 Phenyl 5-thioglucoside compound |
11/08/2007 | WO2007126083A1 Method for stabilization of reduced coenzyme q10 |
11/08/2007 | WO2007126043A1 Use as drugs of carboxylic acid derivatives having thiazole rings |
11/08/2007 | WO2007125952A1 Amine derivative having npy y5 receptor antagonist activity |
11/08/2007 | WO2007125915A1 Solid matter containing coenzyme q |
11/08/2007 | WO2007125720A1 Molecular chaperone expression inducer |
11/08/2007 | WO2007125644A1 Fat absorption inhibitor |
11/08/2007 | WO2007125621A1 Novel use of gene whose expression is increased in hyperplastic pancreatic islet |
11/08/2007 | WO2007125405A2 Substituted 2-amino-fused heterocyclic compounds |
11/08/2007 | WO2007125351A1 Pyrimidine derivatives for the treatment of amyloid-related diseases |
11/08/2007 | WO2007125243A1 Use of saffron and/or safranal and/or crocin and/or picrocrocin and/or derivatives thereof as a sateity agent for treatment of obesity |
11/08/2007 | WO2007125103A2 Benzamide glucokinase activators |
11/08/2007 | WO2007125049A1 Use of cbx cannabinoid receptor modulators as potassium channel modulators |
11/08/2007 | WO2007125048A1 Pharmaceutical compositions comprising cbx cannabinoid receptor modulators and potassium channel modulators |
11/08/2007 | WO2007124734A2 Compounds a-r-x for the manufacture of pharmaceutical preparations |
11/08/2007 | WO2007124668A1 Pharmaceutical composition comprising high concentrate of polydatin |
11/08/2007 | WO2007124618A1 Insulin-like growth factor-enriched nano-products of hairy antler and process for preparation thereof |
11/08/2007 | WO2007124617A1 Coumarin derivatives, their preparation methods and their pharmaceutic compositions and uses |
11/08/2007 | WO2007109884A8 Fat-trapping composition comprising an indigestible cationic polysaccharide and an emulsifying agent |
11/08/2007 | WO2007109037A3 Thiazolidinedione analogues for the treatment of hypertension and for lowering lipids |
11/08/2007 | WO2007089557A3 Polycyclic 1, 2, 3, 4 -tetrahydro- isoquinoline derivatives and compositions comprising them as ppar modulators |
11/08/2007 | WO2007075534A3 Polymer conjugates of glp-1 |
11/08/2007 | WO2007074406A3 Formulations for treatment of lipoprotein abnormalities comprising a statin a statin and a methylnicotinamide derivative |
11/08/2007 | WO2007071357A3 Pharmaceutical composition comprising (e) -7- [4- (4-fluorophenyl) -6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin-5 -yl- (3r, 5s) -3, 5-dihydr0xyhept-6-en0ic acid |
11/08/2007 | WO2007038801A3 Monovalent cation-binding compositions comprising core-shell particles having crosslinked poly-vinylic shells, and methods of use thereof |
11/08/2007 | WO2006106423A8 Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase |
11/08/2007 | WO2002046458A9 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
11/08/2007 | WO2002022146A3 Components of canola for treating hyperlipidemia |
11/08/2007 | US20070259961 Novel acyl urea, thiourea, carbamate, thiocarbamate and related compounds are provided which are effective in inhibiting the cytokine-mediated inflammatory response in cultured cells, in ameliorating bone destruction in an animal model of arthritis and in lowering blood glucose levels in animal or cancer |
11/08/2007 | US20070259927 Remedy for Diabetes |
11/08/2007 | US20070259925 Dpp iv inhibitors |
11/08/2007 | US20070259918 2-Hydroxymethyl-3,4,5-Trihydroxy-1-(4-Pentyloxybenzyl) Piperidine as Glucosylceramide Synthase (Gcs) Inhibitor |
11/08/2007 | US20070259908 Mitochondria Activators |
11/08/2007 | US20070259904 Bi-aryl meta-pyrimidine inhibitors of kinases |
11/08/2007 | US20070259902 Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer |
11/08/2007 | US20070259896 N-[3-(3-{[5-(4-Fluorophenyl)thieno[2,3-d]pyrimidin-4-yl]oxy}propoxy)phenyl]cyclopropanecarboxamide; PDE10 inhibitor; psychological, nervous system disorders; schizophrenia; cognition activators; drug abuse; antiepileptic agents; lupus; antitumor, -carcinogenic agents; hyperglycemica agents; sarcoidosis |
11/08/2007 | US20070259891 Heterocycle-Substituted Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase Inhibitors |
11/08/2007 | US20070259887 Inhibitors of polyq-aggregation |
11/08/2007 | US20070259884 4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity |
11/08/2007 | US20070259883 Substitued A-Piperazingly Phenylpropionic Acid Derivatives As Hppar Alpha And/Or Hppar Gamma Agonists |
11/08/2007 | US20070259880 dipeptidyl peptidase IV (DPP-IV) inhibitors, useful for the prophylaxis or treatment of non-insulin dependent diabetes and obesity |
11/08/2007 | US20070259872 Inhibitors of soluble adenylate cyclase |
11/08/2007 | US20070259815 Albumin fusion proteins |
11/08/2007 | US20070259061 Extract oily phase by cold press and solvent; use as nutritional supplements, in cosmetics |
11/08/2007 | US20070259057 Wrinkle Reduction Agent, Lipolysis Accelerator, Composition for External Use on Skin, and Food or Beverage Composition |
11/08/2007 | US20070258980 Vascular endothelial cell growth factor antagonists and uses thereof |
11/08/2007 | US20070258974 Diagnostics and Therapeutics for Diseases Associated with Puromycin Sensitive Aminopeptidase Npepps (Npepps) |
11/08/2007 | US20070258961 Cholesterol efflux and uses thereof |
11/08/2007 | US20070258920 Process for obtaining polyphenol extracts from cocoa beans, the resulting extracts and uses thereof |
11/08/2007 | CA2684999A1 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
11/08/2007 | CA2669708A1 Benzamide glucokinase activators |
11/08/2007 | CA2651072A1 Substituted 2-amino-fused heterocyclic compounds |
11/08/2007 | CA2650686A1 Method for stabilization of reduced coenzyme q10 |
11/08/2007 | CA2650683A1 Amine derivative having npy y5 receptor antagonist activity |
11/08/2007 | CA2650638A1 Methods for treating diabetes |
11/08/2007 | CA2650627A1 Pieridinyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
11/08/2007 | CA2650577A1 Use of 12-imidazolyl-1-dodecanol or its pharmaceutically acceptable salts for producing a pharmaceutical preparation |
11/08/2007 | CA2650567A1 Use of cbx cannabinoid receptor modulators as potassium channel modulators |
11/08/2007 | CA2650566A1 Pharmaceutical compositions comprising cbx cannabinoid receptor modulators and potassium channel modulators |
11/08/2007 | CA2650403A1 Compositions comprising theaflavins and gallates thereof useful as fat absorption inhibitors |
11/08/2007 | CA2650389A1 Pyrimidine derivatives for the treatment of amyloid-related diseases |
11/08/2007 | CA2650132A1 Further medical uses of antisecretory protein |
11/08/2007 | CA2649822A1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
11/08/2007 | CA2649650A1 Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
11/08/2007 | CA2649577A1 Benzamide glucokinase activators |
11/08/2007 | CA2649363A1 Diphenylazetidinone derivates possessing cholesterol absorption inhibitor activity |
11/08/2007 | CA2649111A1 Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
11/08/2007 | CA2648773A1 Multi-membrane immunoisolation system for cellular transplant |
11/08/2007 | CA2648236A1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
11/08/2007 | CA2648019A1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
11/08/2007 | CA2647815A1 Use of ghrelin splice variant for treating hypercholesterolemia and/or high cholesterol and/or high cholesterol complication and/or lipemia and/or lipemia complication and/or coronary heart disease and/or weight management and/or diabetes and/or hyperglycemia |
11/08/2007 | CA2647678A1 Diazepan orexin receptor antagonists |
11/08/2007 | CA2646624A1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
11/08/2007 | CA2634871A1 Treatment of renal disorders, diabetic nephopathy and dyslipidemias |
11/07/2007 | EP1852505A1 Mutations in ion channels |
11/07/2007 | EP1852503A1 Il-13 production inhibitor |
11/07/2007 | EP1852439A1 Spiroketal derivative and use thereof as diabetic medicine |
11/07/2007 | EP1852433A1 Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof |
11/07/2007 | EP1852427A1 Biologically active 4H-Benzo [1,4] oxazin-3-ones |
11/07/2007 | EP1852426A1 Process for production of optically active ppar-activating compound and intermediate of the same |
11/07/2007 | EP1852423A1 Crystal of 4(3h)-quinazolinone derivative |
11/07/2007 | EP1852116A1 Pharmaceutical compositions of amlodipine and atorvastatin |
11/07/2007 | EP1852108A1 DPP IV inhibitor formulations |
11/07/2007 | EP1851216A2 Substituted benzoquinolizines as dpp-iv inhibitors for the treatment of diabetes |
11/07/2007 | EP1851205A2 Pyridazine derivatives and their use as therapeutic agents |
11/07/2007 | EP1851204A1 Naphthalene derivatives as modulators of the glucocorticoid receptor |
11/07/2007 | EP1851202A1 Pyridyl acetic acid compounds |
11/07/2007 | EP1851197A2 Phenylazetidinone derivatives |
11/07/2007 | EP1850848A1 Tetracyclic sulfonamide compounds and methods of use thereof |
11/07/2007 | EP1850845A2 Formulations and dosing regimen for ppar-alpha modulators |
11/07/2007 | EP1850844A2 Spiro-containing compounds and compositions as modulators of steroid hormone nuclear receptors |
11/07/2007 | EP1804795A4 Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease |
11/07/2007 | EP1623977B1 Intermediate compound which is used for the preparation of pioglitazone |
11/07/2007 | EP1613597B1 6-substituted nicotinamide derivatives as opioid receptor antagonists |
11/07/2007 | EP1572203B1 Substituted 4-alkoxyoxazol derivatives as ppar agonists |
11/07/2007 | EP1523486B1 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity |
11/07/2007 | EP1513526B1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators |
11/07/2007 | EP1423707B1 Methods of screening molecules that are used to prevent cardiovascular diseases |
11/07/2007 | EP1361225B1 Compounds substituted with bicyclic amino groups |
11/07/2007 | EP1257281B1 Nucleoside analogs with carboxamidine modified monocyclic base |